CFDE Data Portal | Compound

Compound

	Label	Description
	Staurosporine Compound (Entity type)	A Compound
	FTI 276 Compound (Entity type)	A Compound
	PT-630 Compound (Entity type)	A Compound
	Fumonisin-b1 Compound (Entity type)	A Compound
	SID103904598 Compound (Entity type)	A Compound
	16-hydroxy-16-(hydroxymethyl)-15-methyl-28-oxa-4,14,19-triazaoctacyclo[12.11.2.1^{15,18}.0^{2,6}.0^{7,27}.0^{8,13}.0^{19,26}.0^{20,25}]octacosa-1(26),2(6),7(27),8(13),9,11,20(25),21,23-nonaen-3-one Compound (Entity type)	A Compound
	R406 Compound (Entity type)	A Compound
	SID11110645 Compound (Entity type)	A Compound
	N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide Compound (Entity type)	A Compound
	EXEL-2880/GSK-1363089 Compound (Entity type)	A Compound

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.